The repercussions of missing the serialisation deadline will have a significant and detrimental impact on the success and longevity of non-compliant businesses. Pharma IQ have spoken with two industry experts to understand their perspective on where the pharmaceutical industry stands in regards to FMD compliance, what challenges are being faced in meeting the deadline and the critical actions that need to be taken before 9th February 2019.
We have put together the very best content pieces from 2018 into a handy industry guide. This guide includes: The serialisation track and trace map 2018, tackling tampering in pharma packaging, smart packaging solutions and much more!
By 2020, serialisation is expected to cover 80% of the global drug supply, but disparity between regulations in different parts of the world means high costs and complexity for companies in the supply chain. As global deadlines loom, we have created this printable map to provide an overview of various nations journey to serialisation.
We have spoken with experts in the industry to better understand the specific challenges faced in emerging serialisation markets. This article will examine the issues these countries face in developing and implementing track and trace systems to help reduce the issue of counterfeit drugs and regulate pharmaceutical products as they pass through the supply chain.
As many pharmaceutical manufactures and CMOs are scrambling to implement serialisation and traceability technologies to comply with regulatory mandates, others are simultaneously exploring how these systems can actually go further than compliance - to improve supply chain planning and operations, speed up product recalls, and improve sales and marketing strategies. Pharma IQ spoke with experts in the industry to discuss moving beyond compliance in serialisation and their predictions as to how successful the regulations will be at reducing the presence of counterfeit pharmaceuticals on an international scale.
Ahead of the Serialisation and Traceability Summit 2017 we conducted extensive market research to pinpoint the concerns and priorities of those in the more mature phases of serialisation.